세계의 치료용 항체 시장(2023년판) : 항체 유형별, 유래별, 용도별, 지역별, 국가별 분석, 시장 인사이트, 예측(2019-2029년)

Executive Summary

Azoth Analytics has released a research report titled "Global Therapeutic Antibody Market (2023 Edition)" which provides a complete analysis of the Global Therapeutic Antibody industry in terms of market segmentation By Product Type (Monoclonal Antibody, Bispecific Antibody, Antibody Drug Conjugates, Others), By Source (Fully Human, Humanized, Others), By Application (Oncology, Autoimmune, Infectious disease, Others), By Region and by Country for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, United Kingdom, Germany, France, Spain, China, Japan, South Korea, India). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.

The research report also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market evolution.

The Global Therapeutic Antibody Market is expected to generate USD 428.20 billion by the end of 2029, up from USD 211.2 billion in 2022. A favourable growth element for the global Therapeutic Antibody market is propelled by the increasing prevalence of chronic diseases, advancements in biotechnology, and the potential for personalized medicine. During the forecast period, 2024-2029, Global Therapeutic Antibody is expected to expand at a CAGR of 11.2%. Advances in bioprocessing and manufacturing technologies are ongoing. These improvements can lead to increased efficiency, reduced costs, and a more sustainable production of therapeutic antibodies.

According to the World Health Organization (WHO), Noncommunicable diseases (NCDs) kill 41 million people each year, equivalent to 74% of all deaths globally. The rising incidence of chronic diseases, including cancer, autoimmune disorders, and inflammatory conditions, is a major driver for the therapeutic antibody market. Antibodies can be designed to target specific molecules involved in these diseases, providing targeted and effective treatments.

The COVID-19 pandemic has underscored the importance of therapeutic antibodies in infectious disease management. Antibodies have been developed and authorized for emergency use in the treatment of COVID-19, highlighting their potential in addressing global health challenges. The urgent need for effective treatments during the pandemic has led to expedited development, clinical trials, and regulatory approval processes. This has demonstrated the agility of the industry and regulatory agencies in responding to emerging health crises.

Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. Advances in precision medicine and the discovery of cancer biomarkers contribute to the development of personalized antibody therapies. Identifying specific molecular targets allows for the design of antibodies tailored to individual patients or specific cancer subtypes.

Researchers continue to engineer antibodies with improved specificity and affinity for their target antigens. This can lead to more effective and precise therapeutic interventions with fewer side effects. Development of novel antibody formats, such as nanobodies, bispecific antibodies, and multispecific antibodies, to expand the therapeutic capabilities and applications.

The utilization of humanized sources in the global therapeutic antibody market offers a range of opportunities, from improving safety and efficacy to expanding target portfolios and enabling advanced engineering approaches. These opportunities contribute to the continued growth and diversification of antibody-based therapies. Advances in antibody engineering have allowed the modification of antibody structures for improved therapeutic properties. Techniques include humanization to reduce immunogenicity, affinity maturation for enhanced binding to target antigens, and isotype switching for optimized effector functions.

Scope of the Report

• The report analyses the Therapeutic Antibody Market by Value (USD Billion).
• The report presents the analysis of the Therapeutic Antibody Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
• The report analyses the Therapeutic Antibody Market by Product Type (Monoclonal antibody, Bispecific antibody, Antibody-drug conjugates, Others).
• The report analyses the Therapeutic Antibody Market by Source (Fully human, Humanized, Others).
• The report analyses the Therapeutic Antibody Market by Application (Oncology, Autoimmune, Infectious disease, Others).
• The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by services, by mode of operation & by end users.
• Also, the major opportunities, trends, drivers and challenges of the industry have been analysed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include F. Hoffmann-La Roche AG, Bristol-Myers Squibb Co., AbbVie Inc., Merck & Co., Inc., Johnson & Johnson, Novartis, Regeneron Pharmaceuticals, Takeda Pharmaceuticals, Amgen, Inc., Eli Lilly and Company.

Table of Contents

1. Market Background

• 1.1 Scope and Product Outlook
• 1.2 Executive Summary
• 1.3 Research Methodology

2. Strategic Recommendations

3. Global Therapeutic Antibody Market: Historic and Forecast (2019-2029)

• 3.1 Impact Analysis of Macro Economic Factors on the Global Therapeutic Antibody Market
• 3.2 Pipeline Scenario
• 3.3 Epidemiology: Global Chronic Disease Prevalence
• 3.4 Epidemiology: Global Chronic Disease Incidence
• 3.5 Global Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
• 3.6 Degree of Impact of Covid-19 on Therapeutic Antibody Market
• 3.7 Global Therapeutic Antibody Market Segmentation: By Product Type
  • 3.7.1 Global Therapeutic Antibody Market, By Product Type Overview
  • 3.7.2 Global Therapeutic Antibody Market Size, By Monoclonal Antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.7.3 Global Therapeutic Antibody Market Size, By Bispecific Antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.7.4 Global Therapeutic Antibody Market Size, By Antibody-drug conjugates, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.7.5 Global Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 3.8 Global Therapeutic Antibody Market Segmentation: By Source
  • 3.8.1 Global Therapeutic Antibody Market, By Source Overview
  • 3.8.2 Global Therapeutic Antibody Market Size, By Fully Human, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.8.3 Global Therapeutic Antibody Market Size, By Humanized, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.8.4 Global Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 3.9 Global Therapeutic Antibody Market Segmentation: By Application
  • 3.9.1 Global Therapeutic Antibody Market, By Application Overview
  • 3.9.2 Global Therapeutic Antibody Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.9.3 Global Therapeutic Antibody Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.9.4 Global Therapeutic Antibody Market Size, By Infectious Disease, By Value, 2019H-2029F (USD Billion & CAGR)
  • 3.9.5 Global Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

4. Global Therapeutic Antibody Market, Regional Analysis

• 4.1 Regional Coverage of the Study
• 4.2 Regional Snapshot

5. Americas Therapeutic Antibody Market: Historic and Forecast (2019-2029)

• 5.1 Americas Therapeutic Antibody Market: Snapshot
• 5.2 Americas Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
• 5.3 Americas Therapeutic Antibody Market: Key Factors
• 5.4 Americas Therapeutic Antibody Market: Segment Analysis
• 5.5 Americas Therapeutic Antibody Market Segmentation: By Product Type
  • 5.5.1 Americas Therapeutic Antibody Market, By Product Type Overview
  • 5.5.2 Americas Therapeutic Antibody Market Size, By Monoclonal Antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.5.3 Americas Therapeutic Antibody Market Size, By Bispecific Antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.5.4 Americas Therapeutic Antibody Market Size, By Antibody-drug conjugates, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.5.5 Americas Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 5.6 Americas Therapeutic Antibody Market Segmentation: By Source
  • 5.6.1 Americas Therapeutic Antibody Market, By Source Overview
  • 5.6.2 Americas Therapeutic Antibody Market Size, By Fully Human, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.6.3 Americas Therapeutic Antibody Market Size, By Humanized, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.6.4 Americas Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 5.7 Americas Therapeutic Antibody Market Segmentation: By Application
  • 5.7.1 Americas Therapeutic Antibody Market, By Application Overview
  • 5.2.2 Americas Therapeutic Antibody Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.7.3 Americas Therapeutic Antibody Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.7.4 Americas Therapeutic Antibody Market Size, By Infectious Disease, By Value, 2019H-2029F (USD Billion & CAGR)
  • 5.7.5 Americas Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 5.8 Americas Therapeutic Antibody Market Segmentation: By Country
  • 5.8.1 Americas Therapeutic Antibody Market, By Country Overview
  • 5.8.2 United States Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 5.8.2.1 United States Therapeutic Antibody Market, By Product Type
    • 5.8.2.2 United States Therapeutic Antibody Market, By Source
    • 5.8.2.3 United States Therapeutic Antibody Market, By Application
  • 5.8.3 Canada Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 5.8.3.1 Canada Therapeutic Antibody Market, By Product Type
    • 5.8.3.2 Canada Therapeutic Antibody Market, By Source
    • 5.8.3.3 Canada Therapeutic Antibody Market, By Application
  • 5.10.4 Rest of Americas Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 5.10.4.1 Rest of Americas Therapeutic Antibody Market, By Product Type
    • 5.10.4.2 Rest of Americas Therapeutic Antibody Market, By Source
    • 5.10.4.3 Rest of Americas Therapeutic Antibody Market, By Application

6. Europe Therapeutic Antibody Market: Historic and Forecast (2019-2029)

• 6.1 Europe Therapeutic Antibody Market: Snapshot
• 6.2 Europe Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
• 6.3 Europe Therapeutic Antibody Market: Key Factors
• 6.4 Europe Therapeutic Antibody Market: Segment Analysis
• 6.5 Europe Therapeutic Antibody Market Segmentation: By Product Type
  • 6.5.1 Europe Therapeutic Antibody Market, By Product Type Overview
  • 6.5.2 Europe Therapeutic Antibody Market Size, By Monoclonal antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.5.3 Europe Therapeutic Antibody Market Size, By Bispecific antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.5.4 Europe Therapeutic Antibody Market Size, By Antibody drug conjugates, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.7.5 Europe Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 6.6 Europe Therapeutic Antibody Market Segmentation: By Source
  • 6.6.1 Europe Therapeutic Antibody Market, By Source Overview
  • 6.6.2 Europe Therapeutic Antibody Market Size, By Fully Human, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.6.3 Europe Therapeutic Antibody Market Size, By Humanized, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.6.4 Europe Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 6.7 Europe Therapeutic Antibody Market Segmentation: By Application
  • 6.7.1 Europe Therapeutic Antibody Market, By Application Overview
  • 6.5.2 Europe Therapeutic Antibody Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.5.3 Europe Therapeutic Antibody Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.5.4 Europe Therapeutic Antibody Market Size, By Infectious Disease, By Value, 2019H-2029F (USD Billion & CAGR)
  • 6.7.5 Europe Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 6.8 Europe Therapeutic Antibody Market Segmentation: By Country
  • 6.8.1 Europe Therapeutic Antibody Market, By Country Overview
  • 6.8.2 United Kingdom Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 6.8.2.1 United Kingdom Therapeutic Antibody Market, By Product Type
    • 6.8.2.2 United Kingdom Therapeutic Antibody Market, By Source
    • 6.8.2.3 United Kingdom Therapeutic Antibody Market, By Application
  • 6.8.3 Germany Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 6.8.3.1 Germany Therapeutic Antibody Market, By Product Type
    • 6.8.3.2 Germany Therapeutic Antibody Market, By Source
    • 6.8.3.3 Germany Therapeutic Antibody Market, By Application
  • 6.8.4 France Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 6.8.4.1 France Therapeutic Antibody Market, By Product Type
    • 6.8.4.2 France Therapeutic Antibody Market, By Source
    • 6.8.4.3 France Therapeutic Antibody Market, By Application
  • 6.8.5 Spain Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 6.8.5.1 Spain Therapeutic Antibody Market, By Product Type
    • 6.8.5.2 Spain Therapeutic Antibody Market, By Source
    • 6.8.5.3 Spain Therapeutic Antibody Market, By Application
  • 6.8.7 Rest of Europe Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 6.8.6.1 Rest of Europe Therapeutic Antibody Market, By Product Type
    • 6.8.6.2 Rest of Europe Therapeutic Antibody Market, By Source
    • 6.8.6.3 Rest of Europe Therapeutic Antibody Market, By Application

7. Asia Pacific Therapeutic Antibody Market: Historic and Forecast (2019-2029)

• 7.1 Asia Pacific Therapeutic Antibody Market: Snapshot
• 7.2 Asia Pacific Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
• 7.3 Asia Pacific Therapeutic Antibody Market: Key Factors
• 7.4 Asia Pacific Therapeutic Antibody Market: Segment Analysis
• 7.5 Asia Pacific Therapeutic Antibody Market Segmentation: By Product Type
  • 7.5.1 Asia Pacific Therapeutic Antibody Market, By Product Type Overview
  • 7.5.2 Asia Pacific Therapeutic Antibody Market Size, By Monoclonal antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.5.3 Asia Pacific Therapeutic Antibody Market Size, By Bispecific antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.5.4 Asia Pacific Therapeutic Antibody Market Size, By Antibody-drug conjugates, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.7.5 Asia Pacific Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 7.6 Asia Pacific Therapeutic Antibody Market Segmentation: By Source
  • 7.6.1 Asia Pacific Therapeutic Antibody Market, By Source Overview
  • 7.6.2 Asia Pacific Therapeutic Antibody Market Size, By Fully Human, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.6.3 Asia Pacific Therapeutic Antibody Market Size, By Humanized, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.6.4 Asia Pacific Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 7.7 Asia Pacific Therapeutic Antibody Market Segmentation: By Application
  • 7.7.1 Asia Pacific Therapeutic Antibody Market, By ApplicationOverview
  • 7.7.2 Asia Pacific Therapeutic Antibody Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.7.3 Asia Pacific Therapeutic Antibody Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.5.4 Asia Pacific Therapeutic Antibody Market Size, By Infectious Disease, By Value, 2019H-2029F (USD Billion & CAGR)
  • 7.7.5 Asia Pacific Therapeutic Antibody Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 7.8 Asia Pacific Therapeutic Antibody Market Segmentation: By Country
  • 7.8.1 Asia Pacific Therapeutic Antibody Market, By Country Overview
  • 7.8.2 China Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 7.8.2.1 China Therapeutic Antibody Market, By Product Type
    • 7.8.2.2 China Therapeutic Antibody Market, By Source
    • 7.8.2.3 China Therapeutic Antibody Market, By Application
  • 7.8.3 Japan Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 7.8.3.1 Japan Therapeutic Antibody Market, By Product Type
    • 7.8.3.2 Japan Therapeutic Antibody Market, By Source
    • 7.8.3.3 Japan Therapeutic Antibody Market, By Application
  • 7.8.4 South Korea Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 7.8.4.1 South Korea Therapeutic Antibody Market, By Product Type
    • 7.8.4.2 South Korea Therapeutic Antibody Market, By Source
    • 7.8.4.3 South Korea Therapeutic Antibody Market, By Application
  • 7.8.5 India Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 7.8.5.1 India Therapeutic Antibody Market, By Product Type
    • 7.8.5.2 India Therapeutic Antibody Market, By Source
    • 7.8.5.3 India Therapeutic Antibody Market, By Application
  • 7.8.6 Rest of Asia Pacific Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
    • 7.8.6.1 Rest of Asia Pacific Therapeutic Antibody Market, By Product Type
    • 7.8.6.2 Rest of Asia Pacific Therapeutic Antibody Market, By Source
    • 7.8.6.3 Rest of Asia Pacific Therapeutic Antibody Market, By Application

8. Middle East and Africa Therapeutic Antibody Market: Historic and Forecast (2019-2029)

• 8.1 Middle East and Africa Therapeutic Antibody Market: Snapshot
• 8.2 Middle East and Africa Therapeutic Antibody Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
• 8.3 Middle East and Africa Therapeutic Antibody Market: Key Factors
• 8.4 Middle East and Africa Therapeutic Antibody Market: Segment Analysis
• 8.5 Middle East and Africa Therapeutic Antibody Market Segmentation: By Product Type
  • 8.5.1 Middle East and Africa Therapeutic Antibody Market, By Product Type Overview
  • 8.5.2 Middle East and Africa Therapeutic Antibody Market Size, By Monoclonal Antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.5.3 Middle East and Africa Therapeutic Antibody Market, By Bispecific Antibody, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.5.4 Middle East and Africa Therapeutic Antibody Market Size, By Antibody-drug conjugates, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.7.5 Middle East and Africa Therapeutic Antibody Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 8.6 Middle East and Africa Therapeutic Antibody Market Segmentation: By Source
  • 8.6.1 Middle East and Africa Therapeutic Antibody Market, By Source Overview
  • 8.6.2 Middle East and Africa Therapeutic Antibody Market Size, By Fully Human, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.6.3 Middle East and Africa Therapeutic Antibody Market Size, By Humanized, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.6.4 Middle East and Africa Therapeutic Antibody Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
• 8.7 Middle East and Africa Therapeutic Antibody Market Segmentation: By Application
  • 8.7.1 Middle East and Africa Therapeutic Antibody Market, By Application Overview
  • 8.7.2 Middle East and Africa Therapeutic Antibody Market Size, By Oncology, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.7.3 Middle East and Africa Therapeutic Antibody Market Size, By Autoimmune, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.7.4 Middle East and Africa Therapeutic Antibody Market Size, By Infectious disease, By Value, 2019H-2029F (USD Billion & CAGR)
  • 8.7.5 Middle East and Africa Therapeutic Antibody Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

9. Market Dynamics

• 9.1 Impact Assessment of Market Dynamics on the Global Therapeutic Antibody Market
• 9.2 Drivers
• 9.3 Restraints
• 9.4 Trends

10. Industry Ecosystem Analysis

• 10.1 Porter Analysis

11. Competitive Positioning

• 11.1 Companies' Product Positioning
• 11.2 Market Share of Leading Companies
• 11.3 Company Profiling
  • 11.3.1 F. Hoffmann-La Roche AG
  • 11.3.2 Bristol-Myers Squibb Co.
  • 11.4.3 AbbVie Inc.
  • 11.3.4 Merck & Co., Inc.
  • 11.3.5 Johnson & Johnson
  • 11.3.6 Novartis
  • 11.3.7 Regeneron Pharmaceuticals
  • 11.3.8 Takeda Pharmaceuticals
  • 11.3.9 Amgen, Inc.
  • 11.3.10 Eli Lilly and Company